Cargando…

A Systematic Review of Glioblastoma-Targeted Therapies in Phases II, III, IV Clinical Trials

SIMPLE SUMMARY: This review describes in a very detailed and exhaustive approach the literature of these last 20 years on glioblastoma targeted therapies in Phases II-IV of 257 clinical trials on adults with newly diagnosed or recurrent GBMs (excluding targeted immunotherapies and therapies targetin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cruz Da Silva, Elisabete, Mercier, Marie-Cécile, Etienne-Selloum, Nelly, Dontenwill, Monique, Choulier, Laurence
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069979/ https://www.ncbi.nlm.nih.gov/pubmed/33918704 http://dx.doi.org/10.3390/cancers13081795

Ejemplares similares

Bioimaging Nucleic-Acid Aptamers with Different Specificities in Human Glioblastoma Tissues Highlights Tumoral Heterogeneity
por: Cruz Da Silva, Elisabete, et al.
Publicado: (2022)

Selection of Nucleic Acid Aptamers Targeting Tumor Cell-Surface Protein Biomarkers
por: Mercier, Marie-Cécile, et al.
Publicado: (2017)

RNA Aptamers Targeting Integrin α5β1 as Probes for Cyto- and Histofluorescence in Glioblastoma
por: Fechter, Pierre, et al.
Publicado: (2019)

Role of Integrins in Resistance to Therapies Targeting Growth Factor Receptors in Cancer
por: Cruz da Silva, Elisabete, et al.
Publicado: (2019)

Expression/activation of α5β1 integrin is linked to the β-catenin signaling pathway to drive migration in glioma cells
por: Renner, Guillaume, et al.
Publicado: (2016)

Expression Analysis of α5 Integrin Subunit Reveals Its Upregulation as a Negative Prognostic Biomarker for Glioblastoma
por: Etienne-Selloum, Nelly, et al.
Publicado: (2021)

Temozolomide-Acquired Resistance Is Associated with Modulation of the Integrin Repertoire in Glioblastoma, Impact of α5β1 Integrin
por: Sani, Saidu, et al.
Publicado: (2022)

Integrins and p53 pathways in glioblastoma resistance to temozolomide
por: Martin, Sophie, et al.
Publicado: (2012)

Blocking EREG/GPX4 Sensitizes Head and Neck Cancer to Cetuximab through Ferroptosis Induction
por: Jehl, Aude, et al.
Publicado: (2023)

Glioblastoma Metabolism: Insights and Therapeutic Strategies
por: Bernhard, Chloé, et al.
Publicado: (2023)

Imposing Phase II and Phase III Clinical Trials of Targeted Drugs for Glioblastoma: Current Status and Progress
por: Wang, Yaning, et al.
Publicado: (2021)

Role of Endocytosis Proteins in Gefitinib-Mediated EGFR Internalisation in Glioma Cells
por: Cruz Da Silva, Elisabete, et al.
Publicado: (2021)

Inefficiencies in phase II to phase III transition impeding successful drug development in glioblastoma
por: Balasubramanian, Adithya, et al.
Publicado: (2020)

Multiparametric MRI-based differentiation of WHO grade II/III glioma and WHO grade IV glioblastoma
por: Wiestler, Benedikt, et al.
Publicado: (2016)

A phase II study of oral piritrexim in recurrent high-grade (III, IV) glioma.
por: Bleehen, N. M., et al.
Publicado: (1995)

Caveolin-1-negative head and neck squamous cell carcinoma primary tumors display increased epithelial to mesenchymal transition and prometastatic properties
por: Jung, Alain C., et al.
Publicado: (2015)

Concerted Regulation of cGMP and cAMP Phosphodiesterases in Early Cardiac Hypertrophy Induced by Angiotensin II
por: Mokni, Walid, et al.
Publicado: (2010)

Identification and functional prediction of mitochondrial complex III and IV mutations associated with glioblastoma
por: Lloyd, Rhiannon E., et al.
Publicado: (2015)

Integrin α5β1, the Fibronectin Receptor, as a Pertinent Therapeutic Target in Solid Tumors
por: Schaffner, Florence, et al.
Publicado: (2013)

A DNA Repair and Cell Cycle Gene Expression Signature in Pediatric High-Grade Gliomas: Prognostic and Therapeutic Value
por: Entz-Werlé, Natacha, et al.
Publicado: (2021)

Exposure to Endocrine Disrupting Chemicals and Risk of Breast Cancer
por: Eve, Louisane, et al.
Publicado: (2020)

Draft Minutes Annex I, II, III, IV
Publicado: (1966)

Ortsaufgeloeste Photoluminiszensmessungen an III-IV und II-VI Halbleitermaterialien
por: Gloeckler, T
Publicado: (2001)

Hereditary sensory and autonomic neuropathies: types II, III, and IV
por: Axelrod, Felicia B, et al.
Publicado: (2007)

Environmentally Sensitive Fluorescent Sensors Based on Synthetic Peptides
por: Choulier, Laurence, et al.
Publicado: (2010)

Cav1/EREG/YAP Axis in the Treatment Resistance of Cav1-Expressing Head and Neck Squamous Cell Carcinoma
por: Burgy, Mickaël, et al.
Publicado: (2021)

Safety of Ipragliflozin in Patients with Type 2 Diabetes Mellitus: Pooled Analysis of Phase II/III/IV Clinical Trials
por: Kashiwagi, Atsunori, et al.
Publicado: (2019)

60 Studi in II. III. IV. V. VI. VII. posizione
por: Curci, Alberto
Publicado: (1958)

Angiotensin II, III, and IV may be important in the progression of COVID-19
por: Cure, Erkan, et al.
Publicado: (2020)

Angiogenesis Inhibition by a Short 13 Amino Acid Peptide Sequence of Tetrastatin, the α4(IV) NC1 Domain of Collagen IV
por: Vautrin-Glabik, Alexia, et al.
Publicado: (2020)

CLRM-18 SCREEN FAILURES IN PHASE III GLIOBLASTOMA CLINICAL TRIALS
por: Peters, Katherine
Publicado: (2022)

Disparity in outcome prediction between APACHE II, APACHE III and APACHE IV
por: Haddad, Z, et al.
Publicado: (2008)

Diversity of the Germination Apparatus in Clostridium botulinum Groups I, II, III, and IV
por: Brunt, Jason, et al.
Publicado: (2016)

A Short History of Nautical Medicine (Parts I, II, III, IV)
por: Roddis, Louis H.
Publicado: (1941)

NAFLD and nutraceuticals: a review of completed phase III and IV clinical trials
por: Hegazi, Omar E., et al.
Publicado: (2023)

Evaluation of the Cytotoxicity of Cationic Polymers on Glioblastoma Cancer Stem Cells
por: McCartin, Conor, et al.
Publicado: (2022)

Immune biomarker correlates from a Phase II study of ipilimumab (IPI) with carboplatin and paclitaxel (CP) in patients with unresectable stage III or IV metastatic melanoma (MM)
por: Lapointe, Réjean, et al.
Publicado: (2015)

Multiscale Selectivity and in vivo Biodistribution of NRP-1-Targeted Theranostic AGuIX Nanoparticles for PDT of Glioblastoma
por: Gries, Mickaël, et al.
Publicado: (2020)

Pathology. Parts III and IV
Publicado: (1937)

Radiomics approach for preoperative identification of stages I−II and III−IV of esophageal cancer
por: Wu, Lei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ni8dtron82bgf3fvii6vu4rgj4